Lv4
640 积分 2024-05-11 加入
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
14天前
已完结
Randomized phase 2b dose-escalation trial of stem cell therapy with laromestrocel for aging frailty
22天前
已完结
A new strategy for systematically classifying HLA alleles into serological specificities: Update and refinement
1个月前
已关闭
A snapshot of human leukocyte antigen (HLA) diversity using data from the Allele Frequency Net Database
1个月前
已完结
Donor Age Correlates With Liver-Resident Natural Killer Cell Activity in Adoptive Immunotherapy Using Donor Liver Natural Killer Cells in Liver Transplantation
1个月前
已完结
The progress of natural killer cells in the treatment of immune response to hepatocellular carcinoma
1个月前
已关闭
NK cell-based immunotherapy in hepatocellular carcinoma: An attractive therapeutic option for the next decade
1个月前
已完结
Cancer cell metabolism and antitumour immunity
3个月前
已完结
Platelet‐Drug Conjugates Engineered via One‐step Fusion Approach for Metastatic and Postoperative Cancer Treatment
4个月前
已完结
Targeting platelet-tumor cell interactions: a novel approach to cancer therapy
4个月前
已完结
皖公网安备34019202002308
